Peters' anomaly is characterized by a central corneal opacity with corresponding defects in the posterior stroma, Descemet's membrane, and endothelium. We present 2 cases that showed corneal opacity when examined by topical endoscopic imaging (TEI). Case 1 was a 20-day-old neonatal female who had a central corneal opacity in the left eye. TEI showed that the iris stroma was adhered toward the back of the opacified cornea. Case 2 was a 4-month-old male who had a bilateral corneal opacity. TEI revealed that both a keratolenticular adhesion and a surrounding iridocorneal adhesion were observed behind the area of corneal opacity. The patient was diagnosed as having Peters' anomaly with persistent fetal vasculature. This study demonstrates that TEI is a novel method capable of looking into an eye from only a small area of the clear cornea.

Peters' anomaly is the most common cause of congenital corneal opacity [1]. This anomaly is characterized by a central corneal opacity with corresponding defects in the posterior stroma, Descemet's membrane, and endothelium [2,3,4,5]. Ultrasound biomicroscopy is a useful tool for detecting associated structural abnormalities such as keratolenticular or iridocorneal adhesions [6]. However, without the patients' cooperation, it can be difficult to obtain a desirable image when using this method. Topical endoscopic imaging (TEI) is a new tool that can be used to examine intraocular findings through a clear cornea [7]. Here, we present 2 cases that showed corneal opacity when examined by TEI. The study protocols were approved by the Clinical Research Ethics Committee of Saga University. After the parents of the patients had been given a written explanation of the study, they all provided written informed consent.

Case 1

A 20-day-old neonatal female was referred to our department because of corneal opacity. The patient was born maturely following an unremarkable pregnancy. Although her right eye (OD) was normal, her left eye (OS) showed a central corneal opacity (fig. 1a). In both eyes, intraocular pressure was within normal ranges. The anterior chamber structures of the OS could be partially visualized through the clear area. Fundus examination showed a normal appearance of the OD and OS except for the superior periphery, which was difficult to observe because of the corneal opacity. Thus, to examine the anterior chamber in detail, we performed TEI with a previously reported method [7,8]. Briefly, the authors used a rigid endoscope with an otoscope 6.0 cm in length and an outer diameter of 4 mm (1215AA; Karl Storz, Tuttlingen, Germany) with a crescent-shaped illuminating tip. A xenon lamp (Xenon Nova 175; Karl Storz) was used as the light source. The endoscope was connected to a digital camera utilizing a 400,000-pixel charge-coupled device image sensor unit, which was connected to a monitor in turn. The patient was placed on a bed in the supine position, and topical anesthetic was instilled into the OS. A spatula was placed between the eyelids, and hydroxyethyl cellulose solution was applied on the corneal surface to protect it and to create an interface that would improve the quality of the image. The endoscope was placed in proximate contact with the cornea and directed such that the angle could be observed. As shown in figure 1b, the iris stroma was adhered toward the back of the opacified area of the cornea, which confirmed the diagnosis.

Case 2

A 4-month-old male was referred to our department because of a bilateral corneal opacity. The patient was born maturely following an unremarkable pregnancy. Our examination demonstrated the presence of a bilateral central corneal opacity and extremely shallow anterior chambers, which made it impossible to observe the fundus in both eyes (fig. 2a). The intraocular pressure measured was 8 mm Hg in the OD and 9 mm Hg in the OS. Ultrasonographic investigations showed the presence of short axial lengths (OD: 16.0 mm; OS: 16.2 mm) and funnel-shaped retinal detachment. No systemic anomalies were detected during this pediatric examination. When TEI was performed via the clear peripheral cornea, both a keratolenticular adhesion and a surrounding iridocorneal adhesion were observed behind the area of corneal opacity (fig. 2b). The patient wasdiagnosed as having Peters' anomaly and persistent fetal vasculature.

Townsend et al. [9 ]have subdividedPeters' anomaly into the following three types: (I) central corneal leukoma only; (II) central corneal leukoma and keratolenticular adhesion, and (III) central corneal leukoma associated with Axenfeld-Rieger mesodermal dysgenesis. Case 1 showed an iridocorneal adhesion, which corresponds to type I, while case 2 displayed bilateral corneal opacity with iridocorneal and keratolenticular adhesions, which matches type II. Case 2 also showed bilateral funnel-shaped total retinal detachment and a short axial length, assuming Peters' anomaly complicated with persistent fetal vasculature, as described previously [10]. In the present cases, we employed the widely used otoscope to perform TEI. Utilization of this method makes it possible to easily visualize the anterior segment structure via a small clear area of the cornea [7,8]. When TEI was used to examine case 1, a small iridocorneal adhesion positioned toward the back of the corneal lesion was observed. In contrast, a prior ultrasound biomicroscopy examination of the same case could not detect this adhesion. Moreover, utilization of this method in case 2 revealed a partially formed and extremely narrow anterior chamber with iridocorneal and keratolenticular adhesions. Therefore, this study demonstrates that TEI is a novel method that is capable of looking into an eye from only a small area of the clear cornea, although the image obtained with this system is a monocular image and its resolution is restricted by the performance of the charge-coupled device. In addition, this technique may also be helpful when investigating congenital abnormalities in the anterior chamber, angle, iris, and lens, especially in patients unable to remain in a sitting position [7].

1.
Rezende RA, Uchoa UB, Uchoa R, Rapuano CJ, Laibson PR, Cohen EJ: Congenital corneal opacities in a cornea referral practice. Cornea 2004;23:565-570.
2.
Nakanishi I, Brown SI: The histopathology and ultrastructure of congenital, central corneal opacity (Peters' anomaly). Am J Ophthalmol 1971;72:801-812.
3.
Kuper C, Kuwabara T, Stark WJ: The histopathology of Peters' anomaly. Am J Ophthalmol 1975;80:653-660.
4.
Polack FM, Graue EL: Scanning electron microscopy of congenital corneal leukomas (Peters' anomaly). Am J Ophthalmol 1979;88:169-178.
5.
Myles WM, Flanders ME, Chitayat D, Brownstein S: Peters' anomaly: a clinicopathologic study. J Pediatr Ophthalmol Strabismus 1992;29:374-381.
6.
Nischal KK, Naor J, Jay V, MacKeen LD, Rootman DS: Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy. Br J Ophthalmol 2002;86:62-69.
7.
Hirata A, Ishikawa S, Okinami S: Observation of peripheral retina by topical endoscopic imaging method - a preliminary study. Ophthalmol Ther 2013;2:11-18.
8.
Hirata A, Okinami S: Viability of topical endoscopic imaging system for vitreous surgery in rabbit eyes. Ophthalmic Surg Lasers Imaging 2012;43:e64-e67.
9.
Townsend WM, Font RL, Zimmerman LE: Congenital corneal leukomas. 3. Histopathologic findings in 13 eyes with noncentral defect in Descemet's membrane. Am J Ophthalmol 1974;77:400-412.
10.
Matsubara A, Ozeki H, Matsunaga N, Nozaki M, Ashikari M, Shirai S, Ogura Y: Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous. Br J Ophthalmol 2001;85:1421-1425.
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.